NME
TEVA icon

Notis-McConarty Edward’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Notis-McConarty Edward’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-17,221
Closed -$690K – 112
2013
Q4 		$690K Buy
+17,221
New +$678K 0.48% 62

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

Notis-McConarty Edward's TEVA Position: Q1 2014 in Review

Notis-McConarty Edward sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2014, closing a stake of 17,221 shares — an estimated $690K sold.

Notis-McConarty Edward first reported a position in TEVA in Q4 2013 and held it in 1 quarter. The position peaked at $690K in Q4 2013. 772 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Notis-McConarty Edward reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2014 after selling out during the quarter.
  • Notis-McConarty Edward sold 17,221 Teva Pharmaceutical Industries Limited shares in Q1 2014, an estimated $690K.
  • Notis-McConarty Edward first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 1 quarter.
  • Notis-McConarty Edward's Teva Pharmaceutical Industries Limited position peaked at $690K in Q4 2013.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2014.

Based on Notis-McConarty Edward's 13F filing for Q1 2014, filed 29 May 2014.